Kimihiko Ishimura

505 total citations
16 papers, 359 citations indexed

About

Kimihiko Ishimura is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Kimihiko Ishimura has authored 16 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Kimihiko Ishimura's work include Coronary Interventions and Diagnostics (4 papers), Cardiovascular Health and Disease Prevention (4 papers) and Heart Failure Treatment and Management (3 papers). Kimihiko Ishimura is often cited by papers focused on Coronary Interventions and Diagnostics (4 papers), Cardiovascular Health and Disease Prevention (4 papers) and Heart Failure Treatment and Management (3 papers). Kimihiko Ishimura collaborates with scholars based in Japan and United States. Kimihiko Ishimura's co-authors include Hiroaki Matsuoka, Toshio Nishikimi, Hiroshi Yagi, Shigeo Horinaka, Kazumi Akimoto, Hidehiko Ono, Hitoshi Hara, Kazuyoshi Tadokoro, Toshihiko Ishimitsu and Kenji Kangawa and has published in prestigious journals such as PLoS ONE, The American Journal of Medicine and Hypertension.

In The Last Decade

Kimihiko Ishimura

16 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimihiko Ishimura Japan 10 210 92 85 71 54 16 359
Paul Fennessy Australia 9 236 1.1× 127 1.4× 68 0.8× 51 0.7× 104 1.9× 13 474
Françoise Praddaude France 14 146 0.7× 102 1.1× 31 0.4× 50 0.7× 56 1.0× 17 434
Naoya Fukunaga Japan 10 192 0.9× 113 1.2× 42 0.5× 65 0.9× 42 0.8× 20 403
Fenghe Du China 13 98 0.5× 116 1.3× 60 0.7× 48 0.7× 35 0.6× 28 386
Jaw-Wen Chen Taiwan 13 111 0.5× 108 1.2× 73 0.9× 64 0.9× 33 0.6× 26 406
Gerald E. Harders United States 10 328 1.6× 86 0.9× 51 0.6× 41 0.6× 49 0.9× 18 449
Kojiro Ichikawa Japan 11 165 0.8× 62 0.7× 51 0.6× 36 0.5× 95 1.8× 14 390
Yuko Tsurumi‐Ikeya Japan 15 307 1.5× 97 1.1× 74 0.9× 77 1.1× 140 2.6× 19 473
Toyohisa Jinno Japan 9 219 1.0× 113 1.2× 94 1.1× 15 0.2× 95 1.8× 12 403

Countries citing papers authored by Kimihiko Ishimura

Since Specialization
Citations

This map shows the geographic impact of Kimihiko Ishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimihiko Ishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimihiko Ishimura more than expected).

Fields of papers citing papers by Kimihiko Ishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimihiko Ishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimihiko Ishimura. The network helps show where Kimihiko Ishimura may publish in the future.

Co-authorship network of co-authors of Kimihiko Ishimura

This figure shows the co-authorship network connecting the top 25 collaborators of Kimihiko Ishimura. A scholar is included among the top collaborators of Kimihiko Ishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimihiko Ishimura. Kimihiko Ishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sakuma, Masashi, Shigeru Toyoda, Takuo Arikawa, et al.. (2022). Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial. PLoS ONE. 17(1). e0261445–e0261445. 12 indexed citations
2.
Sakuma, Masashi, Shigeru Toyoda, Takuo Arikawa, et al.. (2018). The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol—study protocol. Clinical and Experimental Nephrology. 22(6). 1379–1386. 14 indexed citations
3.
Horinaka, Shigeo, et al.. (2015). Central blood pressure estimation by using N-point moving average method in the brachial pulse wave. Hypertension Research. 38(5). 336–341. 2 indexed citations
4.
5.
Horinaka, Shigeo, et al.. (2011). Cardio-Ankle Vascular Index Could Reflect Plaque Burden in the Coronary Artery. Angiology. 62(5). 401–408. 37 indexed citations
6.
Ishimura, Kimihiko, Toshio Nishikimi, Takeshi Horio, et al.. (2009). OE-136 Prognostic Value of Combination of Adrenomedullin and Brain Natriuretic Peptide in Patients with Stable Cardiovasculer Disease(OE23,Heart Failure (Pathophysiology) (M),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society). Japanese Circulation Journal-english Edition. 73. 208–209. 8 indexed citations
7.
Nishikimi, Toshio, Kimihiko Ishimura, Kazuyoshi Tadokoro, et al.. (2009). Natriuretic peptide/natriuretic peptide receptor-A (NPR-A) system has inhibitory effects in renal fibrosis in mice. Regulatory Peptides. 154(1-3). 44–53. 36 indexed citations
8.
Nishikimi, Toshio, Kimihiko Ishimura, Kazuyoshi Tadokoro, et al.. (2009). Effects of Long-Term Intravenous Administration of Adrenomedullin (AM) Plus hANP Therapy in Acute Decompensated Heart Failure A Pilot Study. Circulation Journal. 73(5). 892–898. 34 indexed citations
9.
Horinaka, Shigeo, et al.. (2008). Comparison of Atherosclerotic Indicators between Cardio Ankle Vascular Index and Brachial Ankle Pulse Wave Velocity. Angiology. 60(4). 468–476. 60 indexed citations
10.
Nishikimi, Toshio, et al.. (2007). Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats. Journal of Hypertension. 25(5). 1053–1063. 37 indexed citations
11.
Nishikimi, Toshio, et al.. (2006). Long-Term Administration of Rho-Kinase Inhibitor Ameliorates Renal Damage in Malignant Hypertensive Rats. Hypertension. 47(6). 1075–1083. 58 indexed citations
12.
Ishimura, Kimihiko, Toshio Nishikimi, Kazumi Akimoto, et al.. (2005). Renoprotective effect of long-term combined treatment with adrenomedullin and omapatrilat in hypertensive rats. Journal of Hypertension. 23(12). 2287–2296. 7 indexed citations
13.
14.
Nishikimi, Toshio, Xin Wang, Kazumi Akimoto, et al.. (2004). Alteration of renal adrenomedullin and its receptor system in the severely hypertensive rat: effect of diuretic. Regulatory Peptides. 124(1-3). 89–98. 4 indexed citations
15.
Sahara, Makoto, Yuji Oikawa, Hajime Kirigaya, et al.. (2002). Which Cross-sectional Area of the Stented Segment Will Become a Minimal Lumen Area at the Time of In-stent Restenosis?. Japanese Circulation Journal-english Edition. 66. 272. 2 indexed citations
16.
Oikawa, Yuji, Hajime Kirigaya, Tadanori Aizawa, et al.. (2002). Mechanisms of acute gain and late lumen loss after atherectomy in different preintervention arterial remodeling patterns. The American Journal of Cardiology. 89(5). 505–510. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Fennessy Breakdown of academic impact, for papers by Françoise Praddaude Breakdown of academic impact, for papers by Naoya Fukunaga Breakdown of academic impact, for papers by Fenghe Du Breakdown of academic impact, for papers by Jaw-Wen Chen Breakdown of academic impact, for papers by Gerald E. Harders Breakdown of academic impact, for papers by Kojiro Ichikawa Breakdown of academic impact, for papers by Yuko Tsurumi‐Ikeya Breakdown of academic impact, for papers by Toyohisa Jinno
Rankless by CCL
2026